MPA | Pharmacy News

PBM Audit Defense: Key Strategies for Pharmacies in 2022

Posted on April 28, 2022 in: Professional Practice

Pharmacy benefit manager (PBM) audits are becoming increasingly dangerous for pharmacies. While the role of the PBM was initially to reduce costs for all parties involved, abusive PBM practices have led to the opposite in many cases. The problem has become so significant that several states have adopted legislation aimed specifically at targeting abusive PBM practices, and the National Community P...

Read More

Moderna says trial results suggest redesigned vaccines can better protect against variants

Posted on April 20, 2022 in: Professional Practice

The outlook for a better COVID-19 vaccine — one that can defend against new mutations — is improving, with early findings showing that Moderna's reformulated product provides more robust protection than the original. Study results that have yet to be peer-reviewed suggest the bivalent vaccine candidate, which couples the company's existing vaccine with one designed to combat th...

Read More

New, highly transmissible forms of omicron may pose latest covid threat

Posted on April 19, 2022 in: Professional Practice

Highly contagious subvariants of the Omicron strain of coronavirus have arrived in central New York, putting the state and the rest of the country on alert for a potential setback in the COVID-19 pandemic. The new versions, BA.2.12 and BA.2.12.1, reportedly are spreading as much as 27% faster than the original Omicron variant. While the subvariants do not appear to be linked to worse disease sever...

Read More

Workplace Environment Task Force Report Released

Posted on April 05, 2022 in: Professional Practice

Burnout, staffing shortages, medication errors: How can Michigan pharmacy address these and other core issues affecting pharmacy practice? This report addresses key causes and conditions of workplace issues in Michigan pharmacy, including burnout, staffing shortages and medication errors, while providing a framework for moving forward with a list of 10 key recommendations to help impr...

Read More

Second Covid-19 Booster Shot Endorsed by FDA, CDC for Adults 50 and Older

Posted on March 30, 2022 in: Professional Practice

Both FDA and CDC have given the nod for Americans aged 50 years and up to receive a second booster dose of COVID-19 vaccine from Moderna or Pfizer-BioNTech. Older adults should wait at least four months after receiving an initial booster before getting a fourth dose, and the brand of vaccine they received earlier is not a factor. The extra layer of protection is "especially important for ...

Read More

Page 10 of 213